A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Healthcare


Top Healthcare Mobile Apps to Explore in 2020

   by Patrick Bailey    181
Top Healthcare Mobile Apps to Explore in 2020

In the "data age," an estimated 81% of Americans own at least one smartphone. That might lead one to wonder why more people aren't taking advantage of healthcare through mobile apps. Even then, many Americans also tend to own other internet-enabled devices, from desktop computers to laptops, tablets, and more. This trend, in conjunction with the still rampaging COVID-19 pandemic, leads to a situation where technology can serve the general populace through mobile apps. So, what are the best healthcare apps, and what do they do?

[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

   by Andrii Buvailo    586
[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited all the way until the emergence of powerful hardware (GPUs) in the late 1990s. Other complementary technologies played an important role in the AI progress too: new data storage capabilities, cheap cloud infrastructures, advanced deep learning algorithms -- all these things became reality only in the 21st century, effectively setting AI field for exponential development trajectory and commercial practical utility. 

Today AI tech has matured to an extent it has become a strategic factor, a competitive differentiator, not only for individual companies but for the whole industries and countries. Needless to say, healthcare -- one of the major industries -- is an important end-user of AI technologies. Countries that care to adopt AI in their healthcare strategies today will have major competitive benefits for public health and safety tomorrow.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    291
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.